CT Machine Market Report: Trends, Forecast and Competitive Analysis to 2035

CT Machine Market

The future of the global ct machine market looks promising with opportunities in the head, lung, pulmonary angiogram, cardiac, abdominal & pelvic, and extremity markets. The global ct machine market is expected to reach an estimated $8.7 billion by 2035 from $5.8 billion in 2027 with a CAGR of 4.5% from 2027 to 2035. The major drivers for this market are the increasing demand for advanced diagnostic imaging, the rising prevalence of chronic diseases, and the growing adoption of non-invasive diagnostic methods.

• Lucintel forecasts that, within the type category, multi-slice spiral scan CT is expected to witness the highest growth over the forecast period due to advancements in scanning technology and increased resolution of diagnostic images.
• Within the application category, cardiac is expected to witness the highest growth over the forecast period due to a greater prevalence of cardiovascular diseases and subsequent advanced imaging.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to growing medical center investments in the region from hospitals.

Emerging Trends in CT Machine Market

Delivery within the next 5 years will be dominated by the shift to more distributed, software-based diagnosis from the hospital-centered imaging approach. The most significant demand is expected to be for rapid, low dose systems, in emergency and outpatient environments. Lucintel's market view is aligned with large imaging equipment suppliers' capex, while ongoing aging of the population and an elevated risk of cardiovascular disease ensures continued robust demand for replacements.

• Low Dose Imaging: The reduction of radiation dose offered by the 2025 Spectral CT roadmap from Philips and the FDA clearance of systems based on photon counting detectors demonstrate magnitude radiation dose reductions of more than 50% that can be used to expand imaging procedures with low dose protocols.
• Artificial Intelligence: AI assistance for reconstruction and workflow is a focus of GE HealthCare's 2025 materials. With integration of AI for imaging and reporting, Siemens Healthineers focuses on automation for scan-to-result.
• Photon-counting CT: The adoption of photon-counting CT is no longer confined to the research domain, as vendors bring to market detectors that can count each individual X-ray photon. With ultra-high resolution modes approaching 0.2 mm, the Siemens NAEOTOM Alpha will continue to be a significant system for 2025.
• Outpatient Decentralization: The continued growth of ambulatory CT imaging in 2025 increased the preference for, and reimbursement for, community based services. Lower footprint CT systems are more cost effective for remote facilities. The US has over 7,000 imaging centers, creating a nationwide opportunity for decentralized technology. As technology continues to grow, outlying imaging centers will purchase lower capacity and more cost effective systems.
• Lifecycle Sustainability: In the next five years, procurement in Europe will invest in systems that consume less energy and increase the potential of reuse and take back policies. CT Systems also use a significant amount of energy, so an advanced cooling system will influence purchasing decisions for the next decade.

Vendors will see an increase in demand for replacement units due to positive outpatient imaging trends, as well as the demand for more capable detector systems. In order to do so, vendors must have a quick and user friendly software system. In emerging markets, procurement teams will focus more on overall system price, user protection and service, installation, and energy consumption rather than buying all components of the system.

Recent Developments in the CT Machine Market

The replacement cycle for CT machines has begun, driven by the need to replace aging scanners, increased oncology demand, surging volumes of Emergency Department cases, and the C-TAC market. Activity is expected to remain high through 2025-2027, with vendors prioritizing AI and spectral imaging, low-dose scanning, and service-centric scanner sales. Lucintel believes procurement will be strongest where governments fund diagnostic systems and private providers consolidate imaging services.

• AI-related Imaging Premieres: In January 2025, GE HealthCare announced the launch of its next generation CT system, aimed at automating workflow and reconstruction, potentially shortening scanning times and/or increasing scanner availability. This system should increase adoption in locations where the supply of radiologists is generally constrained over the next five years.
• Manufacturing Expansion: Siemens Healthineers continues to expand its manufacturing capacity for CT Systems in Germany, with the company reporting over €1 billion of planned global investment in healthcare technologies in FY 2025. Increased capacity should mitigate replacements order backlogs in Europe and North America.
• Expanded Imaging Focus Partnership: In February 2025, Mayo Clinic and GE HealthCare signed an extended partnership agreement to advance imaging technology and infrastructure along with newer modalities and practices. Contracts in this area will influence purchasing activity, as hospitals will want validation that new scanning systems improve workflow and care over the addition of new hardware.
• Government Approvals: During 2025, the U.S. Food and Drug Administration (FDA) approved the use of photon-counting CT systems. Earlier, the FDA approved similar systems made by Siemens Healthineers. Regulatory approval has the potential to encourage the adoption of more advanced CT scanners for cardiovascular and oncology scans, but the high cost will concentrate the use of such systems in large hospitals.
• Major Contracts: In March 2025, procurement for the Community Diagnostic Centres (CDC) continued as part of the multi-billion-pound (GBP) capital investment program in England's National Health Service (NHS). The focus of procurement was on various diagnostic modalities, including CT. Public procurement at this scale will favor the adoption of high-volume, low-cost systems and will strengthen vendors' knowledge of the replacement cycle.

Hospitals will start demanding integrated systems instead of buying stand-alone scanners, as they will focus on workflow, uptime, and measurable clinical outcomes. Premium technologies will concentrate in large hospitals, while refurbished and mid-range systems will be used in cost-constrained locations. Vendors will shift focus to service contracts, subscription of software, and analytical services on a fleet of their equipment as the procurement shift from equipment ownership to lifecycle performance.

Strategic Growth Opportunities in the CT Machine Market

The balanced reset of ct machine market trends is expected during 2024-2026. As hospital imaging moves toward decreasing radiation exposure combined with increasing diagnostic value and better use of imaging assets, hospital outpatient imaging expands. Lucintel finds potential for growth in clinical workload, artificial intelligence, and replacement demand, especially in healthcare systems with affordable access to high-quality scanners.

• AI-enabled Workflow and Triage: Market focus will shift toward scanners that include AI technologies for automated workflow and triage. By January 2025, the US FDA had reviewed and granted market approval to more than 1,000 AI-enabled medical devices, of which radiology devices dominated. Emphasis on decision support and workflow AI technology will dominate purchasing decisions in the future, as potential buyers will favor AI technologies despite hardware specifications.
• Low-dose and Spectral Imaging: Superior imaging at reduced exposure can command a premium. In March 2025, Siemens Healthineers reported first clinical use of photon counting CT on over 100 units. For the next three to five years, demand for spectral and photon counting CT will dominate in oncology, cardiology and pediatric imaging.
• Outpatient and Ambulatory Imaging: Suppliers can innovate to design low cost, compact imaging equipment for diagnostic centers, clinics, and emergency practice facilities. In February 2025, the United States had more than 9,000 accredited CT facilities through the American College of Radiology accreditation system. Decentralized care will more likely place imaging equipment in areas where speed, constant/predictable cost, and extended hours matter over the capacity of a hospital.
• Emerging Market Access: Regional and international vendors may lower the costs of their systems, bring service locally, and provide financing. In April 2025, the Ayushman Bharat scheme in India reached more than 500 million beneficiaries. The growth of both local insurance and public diagnostic systems will drive constant demand for mid-level CT systems across South Asia, Latin America, and Africa.
• Lifecycle and Aftermarket Services: Contracts, tube replacement, and service upgrades improve equity after installation. In June 2025, the FDA articulated that software and cyber safety were ongoing obligations for connected medical devices. With safety and service at the core, companies will likely retain later-stage market demand as hospitals lengthen equipment lifecycles.

These changes indicate that the market welcomes clinical value over the ability to scan rapidly. Dependable systems integrated with financing and service should all capture a larger share of replacement and original equipment procurement. Purchasers will request systems that significantly decrease total ownership and provide measurable workflow improvements and connectivity. Integrated systems will capture the market over software companies focused on imaging, but leave plenty of space for both.

CT Machine Market Drivers and Challenges

The ct machine market is impacted by technological advancements, increase in demand for diagnostics, healthcare expenditure and amendments in regulations. Increasing investment in healthcare creates a need for hospitals and imaging centers for equipment that offers fast, safe and accurate imaging. Improving clinical analytics and artificial intelligence along with the use of photon-counting technology in imaging increases the potential of clinical imaging. Limitations created by the economy, shortages in workforce, cyber safety, and prolonged reimbursement create challenges. Innovation of safe and cost effective technology that balances sustainability and equitable access across developed and developing healthcare systems will determine the success of Lucintel in creating a market.

The factors responsible for driving this market include:

• Increasing Diagnostic Demand: The rising numbers of aging, chronic and cancer populations create a greater need for early diagnosis and screening. The World Health Organization projected that in 2025 approximately 41 million people died due to noncommunicable diseases. Increased focus on imaging will prompt hospitals and outpatient centers to replace old equipment and purchase new scanners that improve throughput and maintain diagnostic quality."
• Artificial Intelligence Integration: AI advancements in CT examinations make them both faster and more consistent through reconstruction, automated positioning, dose optimization, and even clinical decision support. By 2025, multiple vendors reported construction times measured in seconds rather than minutes, illustrating the practical significance of software-enabled workflows. In the next three to five years, AI is expected to contribute to reducing unnecessary repeat scans, optimize radiology department workflow, increase image quality at lower doses, standardize interpretation across hospitals of varying subspecialty strength, and influence purchasing decisions.
• Photon-Counting Innovation: Photon-counting CT (PC-CT) can directly count each of the individual X-ray photons. This may enable improvements in spatial resolution, material discrimination, and radiation dose. In 2025, most of the vendors offering PC-CT included detector designs that enabled spectral information at multiple energy thresholds. In the next three to five years, it is expected that clinical evidence, broader regulatory clearance, and reduced component costs will converge to allow for greater market penetration of PC-CT in cardiovascular, oncology, and neurology. Initial high unit costs will, however, limit sales to tertiary care centers.
• Outpatient Infrastructure Expansion: Greater diagnostic capacity is being built in diagnostic centers, ambulatory surgery, and regional hospitals in order to reduce the burden on tertiary care hospitals. In 2025, outpatient health care accounted for a large percentage of global health care spending, and many facilities optimized for compact CT scanners and quick installations. In the next three to five years, a decentralized model will create increased demand for CT scanners by encouraging manufacturers to produce easier to use and more flexible financing and service scanners of lower footprints.
• Reducing Radiation and Preserving Resources: Patients and regulators aim to increase the quality of exams and scans and reduce radiation, energy consumption, and contrast media consumption. By 2025, some of the more sophisticated reconstruction methods (using advanced iterative and deep learning technologies) reduced radiation dose by up to 50% when compared to conventional methods. For the next 3 to 5 years, protection of hospitals in meeting safety targets and their commitments regarding the environment will contribute greatly to differentiate equipment purchased by hospitals. Dose transparency, greater energy efficiency, and use of recycled and less expensive components will become increasingly important.

The challenges facing this market include:

• Significant Investment and High Costs of Operation: The high cost of CT scanners is due to the major cost of the scanner, preparation of the site, risk management contract's, special cooling equipment, and the need for specialized staff. By 2025, hospitals could expect to pay over half a million dollars (excluding costs and contract's associated with said equipment) to purchase a single advanced CT scanner, and the cost of photon-counting CT scanners could be significantly higher. In the next 3 to 5 years, the need to purchase equipment could be further delayed in rural and low income areas due to financial constraints, while leasing, selling older models, and other contract's of limited duration equipment and shared services contract's could become more dominant, as well as buying decisions based on the total cost of ownership.
• Regulatory, Reimbursement, and Safety Constraints: Manufacturers face rigorous approval processes while providers deal with uncertainty regarding reimbursement, dose-monitoring obligations, and evolving parameters for artificial intelligence (AI)-enabled clinical software. In 2025, a significant number of healthcare systems continued to use differential reimbursement policies for CT examinations and, as a result, offered variable returns on the investment for expensive equipment. For the next three to five years, specific regulatory policies and payment frameworks will likely cause a lack of standardization, increasing compliance costs and inhibiting innovation in this area and unless regulatory frameworks and policies are established, they will likely cause a lack of standardization and increase compliance costs, likely inhibiting innovation in this area.
• Workforce, Interoperability, and Cyber Security Concerns: Given the shortages in radiologists, technologists, biomedical engineers, and specialized service personnel, available equipment will not improve scanner utilization. In 2025, automation and remote support became the primary source for millions of unfilled vacant health-worker positions and, for the period of three to five years after 2025, inadequate data systems, ransomware attacks, and insufficient training will likely cause a productivity and trustee of the service impact on patients, therefore creating market imperatives for secure connectivity that incorporates standardized interfaces, provides vendor neutral archives, and incorporates intuitive workflows for sustained market expansion.

Improvements in diagnostic demand, outpatient facilities, AI, photon-counting CT machines, and technologies that minimize radiation exposure will positively impact the value of CT machines, driving the market to grow. High costs, inconsistent reimbursements, barriers in regulations, not enough employees, and the lack of security will slow the market's growth. The market will likely grow the greatest where machines offer advanced technologies that improve image quality and are cost-effective, reliable, and easy to service. During the next three to five years, hospitals and imaging centers will purchase systems that enable a rapid and easy reduction of radiation used, medical imaging at an even earlier stage, and greater system flexibility to enhance throughput. Competitive advantage will be measured by how easily improvements in technology can be translated to clinically measurable outcomes that improve systems and reduce costs, increase profit margins, and focus more on the patient.

List of CT Machine Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies ct machine market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ct machine market companies profiled in this report include-

• GE Healthcare
• Siemens Healthcare
• Philips
• Toshiba
• Shimadzu
• Hitachi
• Carestream Healthcare
• NeuroLogica
• Neusoft Medical
• Shenzhen Anke High-tech

CT Machine Market by Segment

The study includes a forecast for the global ct machine market by type, application, and region.

CT Machine Market by Type [Value ($B) from 2019 to 2035]:

• Non-Spiral Scan CT
• Single-Slice Spiral Scan CT
• Multi-Slice Spiral Scan CT

CT Machine Market by Application [Value ($B) from 2019 to 2035]:

• Head
• Lungs
• Pulmonary Angiogram
• Cardiac
• Abdominal & Pelvic
• Extremities
• Others

CT Machine Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the CT Machine Market

Computed tomography is starting 2025-2027 with an emphasis on photon-counting design, AI, and localized production. According to the latest industry report from Lucintel, these trends are projected to alter competitive standing for major players in healthcare. More and more public procurements will be looking at clinical productivity, cybersecurity and post sale support.

• United States: Domestic Production and Advanced Imaging Approvals. In January 2025 GE HealthCare secured a $44 million investment to grow their Wisconsin imaging manufacturing. Additionally, the FDA approved a number of AI-enabled CT scanners in 2025. Growth in local manufacturing to improve supply will shorten delivery times and drive adoption for high throughput systems during the next 3-5 years.
• China: Equipment Developments and Hospital Purchasing. In 2025, United Imaging grew their product lines with the introduction of uCT and photon-counting CT devices. Local production of high-end medical devices with supporting contracts to purchase medical devices for thousands of hospitals continue to be supported by the 14th Five-Year Plan. The combined efforts should improve the domestic market and create more competition for premium CT installations.
• Germany: Photon-Counting Production and Clinical Partnerships. Siemens Healthineers announced the NAEOTOM Alpha series family of photon-counting CT systems and exceeded 1,000 installations globally by November 2024. Siemens' 2025 goals include more expansive clinical software integration. Germany's engineering expertise and reference hospitals will help build a first-to-market approach for photon-counting technology.
• India: Capacity localization and public-health procurement. Siemens Healthineers has invested €30 million and opened the Bengaluru Innovation Campus in 2023. By 2025, Siemens Healthineers will continue local production of engineering services for imaging products. Along with the government's hospital modernization program, this will create more domestic service capacity and enhanced access to advanced CT systems.
• Japan: Precision manufacturing investment and system launches. In 2025, Canon Medical released the Aquilion Serve CT system for broader clinical workflows. Along with other Japanese OEMs, Canon Medical continued embedding deep learning reconstruction and automated positioning, further elevating positioning technology and automation. These technologies will enhance Japan's competitive edge in a global market for CT systems for the next 10 years and satisfy replacement demand in aging hospital fleets.

Features of the Global CT Machine Market

• Market Size Estimates: ct machine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: ct machine market size by type, application, and region in terms of value ($B).
• Regional Analysis: ct machine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the ct machine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ct machine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ct machine market by type (non-spiral scan CT, single-slice spiral scan CT, and multi-slice spiral scan CT), application (head, lungs, pulmonary angiogram, cardiac, abdominal & pelvic, extremities, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?